BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30010917)

  • 1. Subtelomeric methylation distinguishes between subtypes of Immunodeficiency, Centromeric instability and Facial anomalies syndrome.
    Toubiana S; Velasco G; Chityat A; Kaindl AM; Hershtig N; Tzur-Gilat A; Francastel C; Selig S
    Hum Mol Genet; 2018 Oct; 27(20):3568-3581. PubMed ID: 30010917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2.
    van den Boogaard ML; Thijssen PE; Aytekin C; Licciardi F; Kıykım AA; Spossito L; Dalm VASH; Driessen GJ; Kersseboom R; de Vries F; van Ostaijen-Ten Dam MM; Ikinciogullari A; Dogu F; Oleastro M; Bailardo E; Daxinger L; Nain E; Baris S; van Tol MJD; Weemaes C; van der Maarel SM
    Clin Genet; 2017 Oct; 92(4):380-387. PubMed ID: 28128455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative methylome analysis of ICF patients identifies heterochromatin loci that require ZBTB24, CDCA7 and HELLS for their methylated state.
    Velasco G; Grillo G; Touleimat N; Ferry L; Ivkovic I; Ribierre F; Deleuze JF; Chantalat S; Picard C; Francastel C
    Hum Mol Genet; 2018 Jul; 27(14):2409-2424. PubMed ID: 29659838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gene mutations and subtelomeric DNA methylation in immunodeficiency, centromeric instability and facial anomalies syndrome.
    Hu H; Chen C; Shi S; Li B; Duan S
    Autoimmunity; 2019; 52(5-6):192-198. PubMed ID: 31476899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells as a model for telomeric abnormalities in ICF type I syndrome.
    Sagie S; Ellran E; Katzir H; Shaked R; Yehezkel S; Laevsky I; Ghanayim A; Geiger D; Tzukerman M; Selig S
    Hum Mol Genet; 2014 Jul; 23(14):3629-40. PubMed ID: 24549038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-random length distribution of individual telomeres in immunodeficiency, centromeric instability and facial anomalies syndrome, type I.
    Sagie S; Edni O; Weinberg J; Toubiana S; Kozlovski T; Frostig T; Katzin N; Bar-Am I; Selig S
    Hum Mol Genet; 2017 Nov; 26(21):4244-4256. PubMed ID: 28973513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions.
    Yehezkel S; Segev Y; Viegas-Péquignot E; Skorecki K; Selig S
    Hum Mol Genet; 2008 Sep; 17(18):2776-89. PubMed ID: 18558631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome.
    Unoki M; Funabiki H; Velasco G; Francastel C; Sasaki H
    J Clin Invest; 2019 Jan; 129(1):78-92. PubMed ID: 30307408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of telomeric function by DNA methylation differs between humans and mice.
    Toubiana S; Larom G; Smoom R; Duszynski RJ; Godley LA; Francastel C; Velasco G; Selig S
    Hum Mol Genet; 2020 Nov; 29(19):3197-3210. PubMed ID: 32916696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation in disease: Immunodeficiency, Centromeric instability, Facial anomalies syndrome.
    Vukic M; Daxinger L
    Essays Biochem; 2019 Dec; 63(6):773-783. PubMed ID: 31724723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HELLS and CDCA7 comprise a bipartite nucleosome remodeling complex defective in ICF syndrome.
    Jenness C; Giunta S; Müller MM; Kimura H; Muir TW; Funabiki H
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):E876-E885. PubMed ID: 29339483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converging disease genes in ICF syndrome: ZBTB24 controls expression of CDCA7 in mammals.
    Wu H; Thijssen PE; de Klerk E; Vonk KK; Wang J; den Hamer B; Aytekin C; van der Maarel SM; Daxinger L
    Hum Mol Genet; 2016 Sep; 25(18):4041-4051. PubMed ID: 27466202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDCA7 and HELLS suppress DNA:RNA hybrid-associated DNA damage at pericentromeric repeats.
    Unoki M; Sharif J; Saito Y; Velasco G; Francastel C; Koseki H; Sasaki H
    Sci Rep; 2020 Oct; 10(1):17865. PubMed ID: 33082427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel deletion in ZBTB24 in a Lebanese family with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
    Chouery E; Abou-Ghoch J; Corbani S; El Ali N; Korban R; Salem N; Castro C; Klayme S; Azoury-Abou Rjeily M; Khoury-Matar R; Debo G; Germanos-Haddad M; Delague V; Lefranc G; Mégarbané A
    Clin Genet; 2012 Nov; 82(5):489-93. PubMed ID: 21906047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
    de Greef JC; Wang J; Balog J; den Dunnen JT; Frants RR; Straasheijm KR; Aytekin C; van der Burg M; Duprez L; Ferster A; Gennery AR; Gimelli G; Reisli I; Schuetz C; Schulz A; Smeets DFCM; Sznajer Y; Wijmenga C; van Eggermond MC; van Ostaijen-Ten Dam MM; Lankester AC; van Tol MJD; van den Elsen PJ; Weemaes CM; van der Maarel SM
    Am J Hum Genet; 2011 Jun; 88(6):796-804. PubMed ID: 21596365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and rescue of telomeric abnormalities in ICF syndrome type I fibroblasts.
    Yehezkel S; Shaked R; Sagie S; Berkovitz R; Shachar-Bener H; Segev Y; Selig S
    Front Oncol; 2013; 3():35. PubMed ID: 23450006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three novel ZBTB24 mutations identified in Japanese and Cape Verdean type 2 ICF syndrome patients.
    Nitta H; Unoki M; Ichiyanagi K; Kosho T; Shigemura T; Takahashi H; Velasco G; Francastel C; Picard C; Kubota T; Sasaki H
    J Hum Genet; 2013 Jul; 58(7):455-60. PubMed ID: 23739126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects.
    Weemaes CM; van Tol MJ; Wang J; van Ostaijen-ten Dam MM; van Eggermond MC; Thijssen PE; Aytekin C; Brunetti-Pierri N; van der Burg M; Graham Davies E; Ferster A; Furthner D; Gimelli G; Gennery A; Kloeckener-Gruissem B; Meyn S; Powell C; Reisli I; Schuetz C; Schulz A; Shugar A; van den Elsen PJ; van der Maarel SM
    Eur J Hum Genet; 2013 Nov; 21(11):1219-25. PubMed ID: 23486536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Satellite 2 methylation patterns in normal and ICF syndrome cells and association of hypomethylation with advanced replication.
    Hassan KM; Norwood T; Gimelli G; Gartler SM; Hansen RS
    Hum Genet; 2001 Oct; 109(4):452-62. PubMed ID: 11702227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in CDCA7 and HELLS cause immunodeficiency-centromeric instability-facial anomalies syndrome.
    Thijssen PE; Ito Y; Grillo G; Wang J; Velasco G; Nitta H; Unoki M; Yoshihara M; Suyama M; Sun Y; Lemmers RJ; de Greef JC; Gennery A; Picco P; Kloeckener-Gruissem B; Güngör T; Reisli I; Picard C; Kebaili K; Roquelaure B; Iwai T; Kondo I; Kubota T; van Ostaijen-Ten Dam MM; van Tol MJ; Weemaes C; Francastel C; van der Maarel SM; Sasaki H
    Nat Commun; 2015 Jul; 6():7870. PubMed ID: 26216346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.